Home›Stock Screener›Orchid Pharma

Orchid Pharma Share Price Today | Stock Price & Orchid Pharma Share Screener

ORCHPHARMA Pharmaceuticals & Biotechnology
Live Share Price NSE
₹948.60
▼ -7.35 (-0.77%)
2026-11-19 00:00:00
Live Share Price BSE
₹950.45
▼ -4.95 (-0.52%)
2026-11-19 00:00:00

As of November 19, 2026, the live Orchid Pharma share price (NSE: ORCHPHARMA) is ₹948.60 on NSE and ₹950.45 on BSE, down 0.77% from the previous close, with shares trading between ₹927.80 and ₹962.50 in today's trading session, and a 52-week range of ₹482.45–₹1,107.20. Track Orchid Pharma market worth to gauge the company's total market size. Use the Orchid Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Orchid Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹359 and net income of ₹29, with EBITDA of ₹42, an operating margin of 7.0% and a profit margin of 8.1%.

Orchid Pharma Market Cap ₹5,296.25 Cr.
ORCHPHARMA P/E Ratio (TTM) 479.00
Orchid Pharma P/B Ratio 3.28
EPS (TTM) ₹1.66
Dividend Yield -
Debt to Equity 0.15
ORCHPHARMA 52 Week High ₹1107.20
Orchid Pharma 52 Week Low ₹482.45
Operating Margin 7.00%
Profit Margin 8.08%
ORCHPHARMA Revenue (TTM) ₹359.00
EBITDA ₹42.00
Net Income ₹29.00
Total Assets ₹2,258.00
Total Equity ₹1,564.00

Orchid Pharma Share Price Chart

Track the current stock price of Orchid Pharma with an interactive chart. Analyse ORCHPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Orchid Pharma stock quote in one place.

The quote of ₹948.60 sits between the 52-week low of ₹482.45 and the 52-week high of ₹1,107.20, and the latest session moved -0.77% from the previous close.

Orchid Pharma Company Profile - Fundamental Screener

Screen Orchid Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ORCHPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE191A01027.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE191A01027

Orchid Pharma Balance Sheet Screener

Screen ORCHPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,258, up from ₹2,077 in 2025.

Latest statistics put total assets at ₹2,258 and shareholder funds at ₹1,564, with a leverage ratio of 0.15.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 2,258 2,077 1,554 1,225 1,111 1,237 1,460 3,077 3,125 3,256
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 692 708 620 573 584 670 858 1,256 1,386 1,497

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 203 15 124 165 222 442 519 1,436 1,905 2,212
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,564 1,554 1,170 689 647 653 766 -704 -792 -467
Share Capital 60 60 51 41 41 41 41 89 89 89
Reserves & Surplus 1,504 1,494 1,050 579 538 544 725 -793 -881 -556

Orchid Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Orchid Pharma income statement and profit fundamentals. Analyze ORCHPHARMA quarterly results. Orchid Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹359 and net profit was ₹29, equal to earnings per unit of ₹4.77, at an operating margin of 7%.

In that period expenses were ₹317, interest cost ₹4 and tax ₹-2. The next period listed, 2026-Jun, shows revenue of ₹306 and net profit of ₹3.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 359 306 376 213 310 275 241 226 230 252 231 228 207 185 251
Expenses 317 290 338 213 295 269 210 191 192 212 188 185 175 161 177

Operating Costs and Margins

EBITDA 42 16 38 0 15 6 32 35 38 40 42 43 32 24 74
Operating Profit % 7.00% 5.00% 8.00% -3.00% 1.00% -2.00% 12.00% 12.00% 14.00% 13.00% 13.00% 16.00% 12.00% 12.00% 16.00%
Depreciation 11 11 11 9 11 11 9 9 9 8 8 9 8 8 7
Interest 4 2 2 3 3 2 4 4 3 4 4 4 4 6 8

Profit and Earnings

Profit Before Tax 27 3 25 -12 1 -7 19 23 26 28 30 30 20 11 59
Tax -2 -1 -1 1 2 -1 -3 2 -1 -1 -3 1 0 1 0
Net Profit 29 3 26 -13 -1 -6 22 21 27 29 33 29 20 9 59
EPS 4.77 0.54 4.31 -2.49 -0.15 -0.95 4.40 4.10 5.37 5.79 6.81 6.18 4.30 1.85 14.49

Orchid Pharma Cash Flow Screener - Liquidity Fundamentals

Screen ORCHPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹126, and net cash flow was an outflow of ₹14.

Over the same period, investing activities used ₹277 and financing activities provided ₹137.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 126 51 126 18 93 24 81 12 9 401
Investing Activities -277 -37 -312 -31 113 67 167 46 -28 -176

Financing and Net Cash

Financing Activities 137 3 167 31 -217 -165 -250 0 33 -465
Net Cash Flow -14 17 -19 18 -11 -74 -2 57 15 -240

Orchid Pharma Shareholding Pattern Screener

See Orchid Pharma shareholding pattern with promoter, FII, and DII holdings. Check Orchid Pharma promoter holding and ownership changes for ORCHPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 69.84%, foreign institutions 0.87%, domestic institutions 20.25% and the public 6.58%, spread across 35,118 shareholders.

The shareholder count was 35,118 in 2026-Mar, compared with 33,433 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Aug 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 69.84% 69.84% 74.45% 74.45% 69.84% 69.84% 69.84% 69.84%

Institutional Investors

FII Holding 0.87% 0.81% 0.93% 0.93% 2.69% 1.40% 1.56% 1.17%
DII Holding 20.25% 20.75% 17.54% 17.44% 20.10% 19.43% 19.04% 19.39%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.58% 6.21% 5.12% 5.26% 5.11% 6.91% 7.03% 6.76%
Other Holding 2.47% 2.40% 1.95% 1.92% 2.27% 2.43% 2.54% 2.84%
Shareholder Count 35,118 33,433 33,260 33,260 34,303 39,827 38,155 35,709

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Orchid Pharma. Orchid Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Orchid Pharma.

Orchid Pharma Stock Index Membership - Nifty & Sensex

See which indices include Orchid Pharma stock. Check ORCHPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Orchid Pharma Market Events Screener - Corporate Actions

Get Orchid Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Orchid Pharma stock events that may affect ORCHPHARMA share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -0.28%
2026-09-29 2026-09-29 Annual General Meeting NA 9.11%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -3.97%
2026-07-23 2026-07-23 Merger - Demerger 5:161 0.00%
2026-05-25 2026-05-25 Quarterly Result Announcement NA -0.72%
2026-02-11 2026-02-11 Quarterly Result Announcement NA 0.02%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 6.90%
2025-09-20 2025-09-20 Annual General Meeting NA 1.08%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -2.59%
2025-06-26 2025-06-26 Extraordinary General Meeting NA 4.93%
2025-05-26 2025-05-26 Quarterly Result Announcement NA -0.34%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -14.67%
2024-11-11 2024-11-11 Quarterly Result Announcement NA 7.51%
2024-08-21 2024-08-21 Annual General Meeting NA 21.84%

Orchid Pharma Competitors Screener - Peer Stocks Comparison

Screen ORCHPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Orchid Pharma Company Announcements - News & Reports Screener

Screen ORCHPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 19, 2026.

Date Update Actions
2026-11-19 Statement Of Deviation Or Variation For The Quarter Ended September 30 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement (QIP) -
2026-11-19 Declaration Of Financial Results For Quarter And Half Year Ended On September 30 2026 -
2026-11-19 Board Meeting Outcome for Outcome Of Board Meeting -
2026-11-18 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-16 Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On November 14 2026 -
2026-10-24 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-20 Announcement under Regulation 30 (LODR)-Raising of Funds -
2026-10-20 Board Meeting Outcome for Outcome Of Board Meeting -
2026-10-15 Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On October 20 2026. -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-03 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-28 Closure of Trading Window -
2026-09-23 Intimation Under Regulation 30- Trading Approval Of Equity Shares Issued And Allotted Under Scheme Of Amalgamation -
2026-09-22 Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement Regulations) 2015 -
2026-09-21 Investor Roadshow Scheduled To Be Held In Mumbai -
2026-09-08 Reg. 34 (1) Annual Report. -
2026-09-08 Business Responsibility and Sustainability Reporting (BRSR) -
2026-09-07 Notice Of 33Rd Annual General Meeting Of Orchid Pharma Limited (The Company) For The F.Y. 2025-26 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹948.60, within a 52-week range of ₹482.45 to ₹1,107.20. The P/E ratio is 479.00 and the P/B ratio is 3.28, with earnings per unit of ₹1.66. Market capitalisation stands at ₹5,296.25 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.